Don’t send a generic resume — generate a resume and cover letter tailored to this exact role.
Institute of Molecular and Cell Biology (IMCB) in Singapore seeks a Research Officer to support iPSC-based models for glial cell biology and ALS-related projects in the Patani lab. You will participate from experimental design to validation and mechanistic studies, contributing to disease modelling efforts at A*STAR IMCB.
The role offers opportunities to work on disease-relevant cellular models, collaborate with scientists, and advance iPSC culture, differentiation, and biomolecular assays in a
The Institute of Molecular and Cell Biology (IMCB) is a research institute under Singapore’s Agency for Science, Technology and Research (A*STAR). IMCB conducts fundamental and translational biomedical research across areas including neuroscience, cell biology, disease modelling and therapeutic discovery. The institute provides a collaborative environment with access to multidisciplinary expertise, advanced research platforms and partnerships across academia, healthcare and industry.
The Institute of Molecular and Cell Biology (IMCB) is a research institute under Singapore’s Agency for Science, Technology and Research (A*STAR). IMCB conducts fundamental and translational biomedical research across areas including neuroscience, cell biology, disease modelling and therapeutic discovery. The institute provides a collaborative environment with access to multidisciplinary expertise, advanced research platforms and partnerships across academia, healthcare and industry.
We are looking for a Research Officer to support the development human induced pluripotent stem cell (iPSC)-based models to study glial cell biology in neurological and neurodegenerative diseases in the Patani lab at A*STAR IMCB. The Patani lab has played a pioneering role in neurodegenerative disease modelling focused on ALS using human patient derived iPSCs neuronal cultures. With the beginning of this new chapter in A*STAR, the lab is looking for a biologist to join the group. This means that the candidate has the opportunity to be involved in projects starting from experimental design through to target prioritisation, validation and mechanistic deconvolution.
The candidate will have the opportunity to support key projects focused on the role of glia in ALS, and specifically on the role of deregulated RNA metabolism in motor neuron disease (ALS), where the lab has published some key papers (for example: Luisier et al Nature Communications 2018; Tyzack et al Brain 2021; Ziff et al Nature Communications 2023; Ziff et al Neuron 2023; Neeves et al Science Advances 2025) and reviews (for example: Petrić Howe et al Trends in Neuroscience 2023; Patani et al Nature Reviews Neurology 2023; Balendra et al Lancet Neurology 2025).